Kalaris Therapeutics, Inc. (KLRS): SCHEDULE 13D/A filed Feb 17, 2026

Form type

SCHEDULE 13D/A

Filing date

Feb 17, 2026

Accession number

0001699737-26-000007

Filer

Kalaris Therapeutics, Inc. (CIK 1754068)